Your browser doesn't support javascript.
loading
Safety and tolerability profile of daclizumab in patients with relapsing-remitting multiple sclerosis: An integrated analysis of clinical studies.
Giovannoni, Gavin; Kappos, Ludwig; Gold, Ralf; Khatri, Bhupendra O; Selmaj, Krzysztof; Umans, Kimberly; Greenberg, Steven J; Sweetser, Marianne; Elkins, Jacob; McCroskery, Peter.
Afiliación
  • Giovannoni G; Queen Mary University of London, Blizard Institute, Barts and the London School of Medicine and Dentistry, 4 Newark Street, London E1 2AT, UK. Electronic address: g.giovannoni@qmul.ac.uk.
  • Kappos L; Neurology, Departments of Medicine, Clinical Research, Biomedicine, and Biomedical Engineering, University Hospital Basel, Petersgraben 4, CH-4031 Basel, Switzerland. Electronic address: ludwig.kappos@usb.ch.
  • Gold R; Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Gudrunstraße 56, 44791 Bochum, Germany. Electronic address: Ralf.Gold@ruhr-uni-bochum.de.
  • Khatri BO; Center for Neurological Disorders and The Regional Multiple Sclerosis Center, Wheaton Franciscan Health Care St. Francis Hospital, 3237S 16th Street, Milwaukee, WI 53215, USA. Electronic address: bokhatri@aol.com.
  • Selmaj K; Department of Neurology, Medical University of Lodz, ul. Kopcinskiego 22, 90-153 Lodz, Poland. Electronic address: kselmaj@afazja.am.lodz.pl.
  • Umans K; Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: kim.umans@biogen.com.
  • Greenberg SJ; AbbVie Inc., 1 North Waukegan Road, North Chicago, IL 60064, USA. Electronic address: steven.greenberg@abbvie.com.
  • Sweetser M; Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: msweetser@alnylam.com.
  • Elkins J; Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: jake.elkins@biogen.com.
  • McCroskery P; Biogen, 225 Binney Street, Cambridge, MA 02142, USA. Electronic address: peter.mccroskery@biogen.com.
Mult Scler Relat Disord ; 9: 36-46, 2016 Sep.
Article en En | MEDLINE | ID: mdl-27645341
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina G / Esclerosis Múltiple Recurrente-Remitente / Anticuerpos Monoclonales Humanizados / Inmunosupresores Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Mult Scler Relat Disord Año: 2016 Tipo del documento: Article Pais de publicación: Países Bajos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Inmunoglobulina G / Esclerosis Múltiple Recurrente-Remitente / Anticuerpos Monoclonales Humanizados / Inmunosupresores Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Mult Scler Relat Disord Año: 2016 Tipo del documento: Article Pais de publicación: Países Bajos